nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentoxifylline—NT5E—epithelium—esophageal cancer	0.0154	0.0739	CbGeAlD
Pentoxifylline—NT5E—bronchus—esophageal cancer	0.0151	0.0727	CbGeAlD
Pentoxifylline—NT5E—smooth muscle tissue—esophageal cancer	0.0148	0.0712	CbGeAlD
Pentoxifylline—NT5E—trachea—esophageal cancer	0.0136	0.0653	CbGeAlD
Pentoxifylline—ADORA2B—bronchus—esophageal cancer	0.013	0.0623	CbGeAlD
Pentoxifylline—ADORA2B—smooth muscle tissue—esophageal cancer	0.0127	0.0609	CbGeAlD
Pentoxifylline—Caffeine—PIK3CA—esophageal cancer	0.0118	0.407	CrCbGaD
Pentoxifylline—ADORA2B—trachea—esophageal cancer	0.0116	0.0559	CbGeAlD
Pentoxifylline—Dyphylline—PDE4D—esophageal cancer	0.011	0.38	CrCbGaD
Pentoxifylline—PDE5A—epithelium—esophageal cancer	0.00998	0.0479	CbGeAlD
Pentoxifylline—NT5E—lung—esophageal cancer	0.00977	0.0469	CbGeAlD
Pentoxifylline—PDE5A—smooth muscle tissue—esophageal cancer	0.00962	0.0462	CbGeAlD
Pentoxifylline—ADORA2B—lung—esophageal cancer	0.00837	0.0402	CbGeAlD
Pentoxifylline—Meningitis aseptic—Methotrexate—esophageal cancer	0.00819	0.0365	CcSEcCtD
Pentoxifylline—PDE5A—digestive system—esophageal cancer	0.00759	0.0365	CbGeAlD
Pentoxifylline—PDE4A—lung—esophageal cancer	0.00746	0.0358	CbGeAlD
Pentoxifylline—Leukaemia—Methotrexate—esophageal cancer	0.00716	0.0319	CcSEcCtD
Pentoxifylline—PDE4B—bronchus—esophageal cancer	0.00689	0.0331	CbGeAlD
Pentoxifylline—NT5E—lymph node—esophageal cancer	0.00668	0.0321	CbGeAlD
Pentoxifylline—PDE5A—lung—esophageal cancer	0.00634	0.0305	CbGeAlD
Pentoxifylline—PDE4B—trachea—esophageal cancer	0.00619	0.0297	CbGeAlD
Pentoxifylline—ADORA1—lung—esophageal cancer	0.00601	0.0289	CbGeAlD
Pentoxifylline—PDE4A—lymph node—esophageal cancer	0.0051	0.0245	CbGeAlD
Pentoxifylline—Caffeine—CYP1B1—esophageal cancer	0.0048	0.165	CrCbGaD
Pentoxifylline—PDE4B—lung—esophageal cancer	0.00445	0.0214	CbGeAlD
Pentoxifylline—PDE5A—lymph node—esophageal cancer	0.00434	0.0208	CbGeAlD
Pentoxifylline—Infection—Carboplatin—esophageal cancer	0.00425	0.0189	CcSEcCtD
Pentoxifylline—ADORA1—lymph node—esophageal cancer	0.00411	0.0197	CbGeAlD
Pentoxifylline—Laryngitis—Capecitabine—esophageal cancer	0.00359	0.016	CcSEcCtD
Pentoxifylline—Throat sore—Capecitabine—esophageal cancer	0.00359	0.016	CcSEcCtD
Pentoxifylline—Oropharyngeal discomfort—Capecitabine—esophageal cancer	0.00356	0.0159	CcSEcCtD
Pentoxifylline—Body temperature increased—Carboplatin—esophageal cancer	0.00338	0.015	CcSEcCtD
Pentoxifylline—CYP1A2—digestive system—esophageal cancer	0.00327	0.0157	CbGeAlD
Pentoxifylline—PDE4B—lymph node—esophageal cancer	0.00304	0.0146	CbGeAlD
Pentoxifylline—Oropharyngeal pain—Capecitabine—esophageal cancer	0.00285	0.0127	CcSEcCtD
Pentoxifylline—Lacrimation increased—Capecitabine—esophageal cancer	0.00281	0.0125	CcSEcCtD
Pentoxifylline—Nasal congestion—Cisplatin—esophageal cancer	0.0028	0.0125	CcSEcCtD
Pentoxifylline—CYP1A2—lung—esophageal cancer	0.00273	0.0131	CbGeAlD
Pentoxifylline—Anaphylactoid reaction—Cisplatin—esophageal cancer	0.00264	0.0117	CcSEcCtD
Pentoxifylline—Influenza like illness—Capecitabine—esophageal cancer	0.00252	0.0112	CcSEcCtD
Pentoxifylline—Ear pain—Capecitabine—esophageal cancer	0.0022	0.00982	CcSEcCtD
Pentoxifylline—Sleep disorder—Capecitabine—esophageal cancer	0.00217	0.00967	CcSEcCtD
Pentoxifylline—Swelling—Capecitabine—esophageal cancer	0.00213	0.00949	CcSEcCtD
Pentoxifylline—Abdominal discomfort—Cisplatin—esophageal cancer	0.00211	0.00941	CcSEcCtD
Pentoxifylline—Vascular purpura—Capecitabine—esophageal cancer	0.0021	0.00936	CcSEcCtD
Pentoxifylline—Pancytopenia—Cisplatin—esophageal cancer	0.00209	0.00933	CcSEcCtD
Pentoxifylline—Thirst—Capecitabine—esophageal cancer	0.00198	0.0088	CcSEcCtD
Pentoxifylline—Purpura—Capecitabine—esophageal cancer	0.00195	0.00869	CcSEcCtD
Pentoxifylline—Conjunctivitis—Cisplatin—esophageal cancer	0.00191	0.00851	CcSEcCtD
Pentoxifylline—Hepatobiliary disease—Cisplatin—esophageal cancer	0.00186	0.00828	CcSEcCtD
Pentoxifylline—Aplastic anaemia—Methotrexate—esophageal cancer	0.00181	0.00806	CcSEcCtD
Pentoxifylline—Flushing—Cisplatin—esophageal cancer	0.00164	0.00729	CcSEcCtD
Pentoxifylline—Abdominal distension—Capecitabine—esophageal cancer	0.00164	0.00729	CcSEcCtD
Pentoxifylline—Bronchospasm—Capecitabine—esophageal cancer	0.0016	0.00712	CcSEcCtD
Pentoxifylline—Immune system disorder—Cisplatin—esophageal cancer	0.00159	0.0071	CcSEcCtD
Pentoxifylline—Angina pectoris—Capecitabine—esophageal cancer	0.00158	0.00705	CcSEcCtD
Pentoxifylline—Arrhythmia—Cisplatin—esophageal cancer	0.00158	0.00702	CcSEcCtD
Pentoxifylline—Abdominal discomfort—Capecitabine—esophageal cancer	0.00156	0.00694	CcSEcCtD
Pentoxifylline—Pancytopenia—Capecitabine—esophageal cancer	0.00154	0.00687	CcSEcCtD
Pentoxifylline—Erythema—Cisplatin—esophageal cancer	0.00154	0.00684	CcSEcCtD
Pentoxifylline—Flatulence—Cisplatin—esophageal cancer	0.00151	0.00674	CcSEcCtD
Pentoxifylline—Muscle spasms—Cisplatin—esophageal cancer	0.00148	0.00658	CcSEcCtD
Pentoxifylline—Infestation—Capecitabine—esophageal cancer	0.00145	0.00645	CcSEcCtD
Pentoxifylline—Infestation NOS—Capecitabine—esophageal cancer	0.00145	0.00645	CcSEcCtD
Pentoxifylline—Vision blurred—Cisplatin—esophageal cancer	0.00145	0.00645	CcSEcCtD
Pentoxifylline—Anaphylactoid reaction—Methotrexate—esophageal cancer	0.00145	0.00644	CcSEcCtD
Pentoxifylline—Tremor—Cisplatin—esophageal cancer	0.00144	0.00641	CcSEcCtD
Pentoxifylline—Ill-defined disorder—Cisplatin—esophageal cancer	0.00143	0.00635	CcSEcCtD
Pentoxifylline—Anaemia—Cisplatin—esophageal cancer	0.00142	0.00632	CcSEcCtD
Pentoxifylline—Jaundice—Capecitabine—esophageal cancer	0.00141	0.00629	CcSEcCtD
Pentoxifylline—Conjunctivitis—Capecitabine—esophageal cancer	0.00141	0.00627	CcSEcCtD
Pentoxifylline—Malaise—Cisplatin—esophageal cancer	0.00139	0.00617	CcSEcCtD
Pentoxifylline—Caffeine—ABCB1—esophageal cancer	0.00138	0.0475	CrCbGaD
Pentoxifylline—Leukopenia—Cisplatin—esophageal cancer	0.00138	0.00612	CcSEcCtD
Pentoxifylline—Hepatobiliary disease—Capecitabine—esophageal cancer	0.00137	0.0061	CcSEcCtD
Pentoxifylline—Epistaxis—Capecitabine—esophageal cancer	0.00137	0.00609	CcSEcCtD
Pentoxifylline—Convulsion—Cisplatin—esophageal cancer	0.00133	0.00593	CcSEcCtD
Pentoxifylline—Myalgia—Cisplatin—esophageal cancer	0.00131	0.00583	CcSEcCtD
Pentoxifylline—Haemoglobin—Capecitabine—esophageal cancer	0.00131	0.00582	CcSEcCtD
Pentoxifylline—Anxiety—Cisplatin—esophageal cancer	0.0013	0.0058	CcSEcCtD
Pentoxifylline—Haemorrhage—Capecitabine—esophageal cancer	0.0013	0.00579	CcSEcCtD
Pentoxifylline—Hepatitis—Capecitabine—esophageal cancer	0.0013	0.00579	CcSEcCtD
Pentoxifylline—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.0013	0.00578	CcSEcCtD
Pentoxifylline—Discomfort—Cisplatin—esophageal cancer	0.00129	0.00576	CcSEcCtD
Pentoxifylline—Oedema—Cisplatin—esophageal cancer	0.00125	0.00558	CcSEcCtD
Pentoxifylline—Anaphylactic shock—Cisplatin—esophageal cancer	0.00125	0.00558	CcSEcCtD
Pentoxifylline—Infection—Cisplatin—esophageal cancer	0.00125	0.00555	CcSEcCtD
Pentoxifylline—Thrombocytopenia—Cisplatin—esophageal cancer	0.00123	0.00547	CcSEcCtD
Pentoxifylline—Tachycardia—Cisplatin—esophageal cancer	0.00122	0.00545	CcSEcCtD
Pentoxifylline—Skin disorder—Cisplatin—esophageal cancer	0.00122	0.00542	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Cisplatin—esophageal cancer	0.00121	0.0054	CcSEcCtD
Pentoxifylline—Flushing—Capecitabine—esophageal cancer	0.00121	0.00538	CcSEcCtD
Pentoxifylline—Anorexia—Cisplatin—esophageal cancer	0.0012	0.00532	CcSEcCtD
Pentoxifylline—Immune system disorder—Capecitabine—esophageal cancer	0.00118	0.00523	CcSEcCtD
Pentoxifylline—Hypotension—Cisplatin—esophageal cancer	0.00117	0.00522	CcSEcCtD
Pentoxifylline—Arrhythmia—Capecitabine—esophageal cancer	0.00116	0.00518	CcSEcCtD
Pentoxifylline—Abdominal discomfort—Methotrexate—esophageal cancer	0.00116	0.00517	CcSEcCtD
Pentoxifylline—Pancytopenia—Methotrexate—esophageal cancer	0.00115	0.00512	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.00114	0.00509	CcSEcCtD
Pentoxifylline—Erythema—Capecitabine—esophageal cancer	0.00113	0.00504	CcSEcCtD
Pentoxifylline—Dyspnoea—Cisplatin—esophageal cancer	0.00112	0.00498	CcSEcCtD
Pentoxifylline—Flatulence—Capecitabine—esophageal cancer	0.00112	0.00497	CcSEcCtD
Pentoxifylline—Dysgeusia—Capecitabine—esophageal cancer	0.00111	0.00494	CcSEcCtD
Pentoxifylline—Back pain—Capecitabine—esophageal cancer	0.0011	0.00488	CcSEcCtD
Pentoxifylline—Decreased appetite—Cisplatin—esophageal cancer	0.00109	0.00485	CcSEcCtD
Pentoxifylline—Muscle spasms—Capecitabine—esophageal cancer	0.00109	0.00485	CcSEcCtD
Pentoxifylline—Infestation NOS—Methotrexate—esophageal cancer	0.00108	0.0048	CcSEcCtD
Pentoxifylline—Drowsiness—Methotrexate—esophageal cancer	0.00108	0.0048	CcSEcCtD
Pentoxifylline—Infestation—Methotrexate—esophageal cancer	0.00108	0.0048	CcSEcCtD
Pentoxifylline—Vision blurred—Capecitabine—esophageal cancer	0.00107	0.00475	CcSEcCtD
Pentoxifylline—Tremor—Capecitabine—esophageal cancer	0.00106	0.00473	CcSEcCtD
Pentoxifylline—Ill-defined disorder—Capecitabine—esophageal cancer	0.00105	0.00468	CcSEcCtD
Pentoxifylline—Conjunctivitis—Methotrexate—esophageal cancer	0.00105	0.00467	CcSEcCtD
Pentoxifylline—Anaemia—Capecitabine—esophageal cancer	0.00105	0.00466	CcSEcCtD
Pentoxifylline—Sweating—Methotrexate—esophageal cancer	0.00103	0.00461	CcSEcCtD
Pentoxifylline—Feeling abnormal—Cisplatin—esophageal cancer	0.00103	0.0046	CcSEcCtD
Pentoxifylline—Malaise—Capecitabine—esophageal cancer	0.00102	0.00455	CcSEcCtD
Pentoxifylline—Hepatobiliary disease—Methotrexate—esophageal cancer	0.00102	0.00454	CcSEcCtD
Pentoxifylline—Epistaxis—Methotrexate—esophageal cancer	0.00102	0.00453	CcSEcCtD
Pentoxifylline—Leukopenia—Capecitabine—esophageal cancer	0.00101	0.00451	CcSEcCtD
Pentoxifylline—Palpitations—Capecitabine—esophageal cancer	0.001	0.00446	CcSEcCtD
Pentoxifylline—Body temperature increased—Cisplatin—esophageal cancer	0.000991	0.00441	CcSEcCtD
Pentoxifylline—Hypertension—Capecitabine—esophageal cancer	0.000978	0.00435	CcSEcCtD
Pentoxifylline—Haemoglobin—Methotrexate—esophageal cancer	0.000974	0.00433	CcSEcCtD
Pentoxifylline—Haemorrhage—Methotrexate—esophageal cancer	0.000969	0.00431	CcSEcCtD
Pentoxifylline—Hepatitis—Methotrexate—esophageal cancer	0.000969	0.00431	CcSEcCtD
Pentoxifylline—Myalgia—Capecitabine—esophageal cancer	0.000964	0.00429	CcSEcCtD
Pentoxifylline—Chest pain—Capecitabine—esophageal cancer	0.000964	0.00429	CcSEcCtD
Pentoxifylline—Anxiety—Capecitabine—esophageal cancer	0.000961	0.00428	CcSEcCtD
Pentoxifylline—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.000958	0.00426	CcSEcCtD
Pentoxifylline—Discomfort—Capecitabine—esophageal cancer	0.000953	0.00424	CcSEcCtD
Pentoxifylline—Dry mouth—Capecitabine—esophageal cancer	0.000943	0.0042	CcSEcCtD
Pentoxifylline—Confusional state—Capecitabine—esophageal cancer	0.000932	0.00415	CcSEcCtD
Pentoxifylline—Oedema—Capecitabine—esophageal cancer	0.000924	0.00412	CcSEcCtD
Pentoxifylline—Hypersensitivity—Cisplatin—esophageal cancer	0.000924	0.00411	CcSEcCtD
Pentoxifylline—Infection—Capecitabine—esophageal cancer	0.000918	0.00409	CcSEcCtD
Pentoxifylline—Shock—Capecitabine—esophageal cancer	0.000909	0.00405	CcSEcCtD
Pentoxifylline—Thrombocytopenia—Capecitabine—esophageal cancer	0.000905	0.00403	CcSEcCtD
Pentoxifylline—Tachycardia—Capecitabine—esophageal cancer	0.000902	0.00402	CcSEcCtD
Pentoxifylline—Asthenia—Cisplatin—esophageal cancer	0.0009	0.00401	CcSEcCtD
Pentoxifylline—Skin disorder—Capecitabine—esophageal cancer	0.000898	0.004	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Capecitabine—esophageal cancer	0.000894	0.00398	CcSEcCtD
Pentoxifylline—Anorexia—Capecitabine—esophageal cancer	0.000881	0.00392	CcSEcCtD
Pentoxifylline—Immune system disorder—Methotrexate—esophageal cancer	0.000875	0.0039	CcSEcCtD
Pentoxifylline—Hypotension—Capecitabine—esophageal cancer	0.000864	0.00385	CcSEcCtD
Pentoxifylline—Diarrhoea—Cisplatin—esophageal cancer	0.000858	0.00382	CcSEcCtD
Pentoxifylline—Erythema—Methotrexate—esophageal cancer	0.000843	0.00375	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000842	0.00375	CcSEcCtD
Pentoxifylline—Insomnia—Capecitabine—esophageal cancer	0.000836	0.00372	CcSEcCtD
Pentoxifylline—Dysgeusia—Methotrexate—esophageal cancer	0.000826	0.00368	CcSEcCtD
Pentoxifylline—Dyspnoea—Capecitabine—esophageal cancer	0.000824	0.00367	CcSEcCtD
Pentoxifylline—Back pain—Methotrexate—esophageal cancer	0.000816	0.00363	CcSEcCtD
Pentoxifylline—Dyspepsia—Capecitabine—esophageal cancer	0.000814	0.00362	CcSEcCtD
Pentoxifylline—Decreased appetite—Capecitabine—esophageal cancer	0.000804	0.00358	CcSEcCtD
Pentoxifylline—Vomiting—Cisplatin—esophageal cancer	0.000797	0.00355	CcSEcCtD
Pentoxifylline—Vision blurred—Methotrexate—esophageal cancer	0.000795	0.00354	CcSEcCtD
Pentoxifylline—Rash—Cisplatin—esophageal cancer	0.000791	0.00352	CcSEcCtD
Pentoxifylline—Constipation—Capecitabine—esophageal cancer	0.000791	0.00352	CcSEcCtD
Pentoxifylline—Dermatitis—Cisplatin—esophageal cancer	0.00079	0.00352	CcSEcCtD
Pentoxifylline—Ill-defined disorder—Methotrexate—esophageal cancer	0.000782	0.00348	CcSEcCtD
Pentoxifylline—Anaemia—Methotrexate—esophageal cancer	0.000779	0.00347	CcSEcCtD
Pentoxifylline—Feeling abnormal—Capecitabine—esophageal cancer	0.000762	0.00339	CcSEcCtD
Pentoxifylline—Malaise—Methotrexate—esophageal cancer	0.00076	0.00339	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000756	0.00337	CcSEcCtD
Pentoxifylline—Leukopenia—Methotrexate—esophageal cancer	0.000755	0.00336	CcSEcCtD
Pentoxifylline—Nausea—Cisplatin—esophageal cancer	0.000745	0.00332	CcSEcCtD
Pentoxifylline—Urticaria—Capecitabine—esophageal cancer	0.000734	0.00327	CcSEcCtD
Pentoxifylline—Abdominal pain—Capecitabine—esophageal cancer	0.000731	0.00325	CcSEcCtD
Pentoxifylline—Body temperature increased—Capecitabine—esophageal cancer	0.000731	0.00325	CcSEcCtD
Pentoxifylline—Convulsion—Methotrexate—esophageal cancer	0.000731	0.00325	CcSEcCtD
Pentoxifylline—Chest pain—Methotrexate—esophageal cancer	0.000718	0.0032	CcSEcCtD
Pentoxifylline—Myalgia—Methotrexate—esophageal cancer	0.000718	0.0032	CcSEcCtD
Pentoxifylline—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.000713	0.00317	CcSEcCtD
Pentoxifylline—Discomfort—Methotrexate—esophageal cancer	0.000709	0.00316	CcSEcCtD
Pentoxifylline—Confusional state—Methotrexate—esophageal cancer	0.000694	0.00309	CcSEcCtD
Pentoxifylline—Anaphylactic shock—Methotrexate—esophageal cancer	0.000688	0.00306	CcSEcCtD
Pentoxifylline—Infection—Methotrexate—esophageal cancer	0.000684	0.00304	CcSEcCtD
Pentoxifylline—Hypersensitivity—Capecitabine—esophageal cancer	0.000681	0.00303	CcSEcCtD
Pentoxifylline—Thrombocytopenia—Methotrexate—esophageal cancer	0.000674	0.003	CcSEcCtD
Pentoxifylline—Skin disorder—Methotrexate—esophageal cancer	0.000668	0.00298	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Methotrexate—esophageal cancer	0.000665	0.00296	CcSEcCtD
Pentoxifylline—Asthenia—Capecitabine—esophageal cancer	0.000663	0.00295	CcSEcCtD
Pentoxifylline—Anorexia—Methotrexate—esophageal cancer	0.000656	0.00292	CcSEcCtD
Pentoxifylline—Pruritus—Capecitabine—esophageal cancer	0.000654	0.00291	CcSEcCtD
Pentoxifylline—Hypotension—Methotrexate—esophageal cancer	0.000643	0.00286	CcSEcCtD
Pentoxifylline—Diarrhoea—Capecitabine—esophageal cancer	0.000632	0.00282	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000627	0.00279	CcSEcCtD
Pentoxifylline—Insomnia—Methotrexate—esophageal cancer	0.000622	0.00277	CcSEcCtD
Pentoxifylline—Dyspnoea—Methotrexate—esophageal cancer	0.000614	0.00273	CcSEcCtD
Pentoxifylline—Somnolence—Methotrexate—esophageal cancer	0.000612	0.00272	CcSEcCtD
Pentoxifylline—Dizziness—Capecitabine—esophageal cancer	0.000611	0.00272	CcSEcCtD
Pentoxifylline—Dyspepsia—Methotrexate—esophageal cancer	0.000606	0.0027	CcSEcCtD
Pentoxifylline—Decreased appetite—Methotrexate—esophageal cancer	0.000598	0.00266	CcSEcCtD
Pentoxifylline—Vomiting—Capecitabine—esophageal cancer	0.000588	0.00262	CcSEcCtD
Pentoxifylline—Rash—Capecitabine—esophageal cancer	0.000583	0.0026	CcSEcCtD
Pentoxifylline—Dermatitis—Capecitabine—esophageal cancer	0.000582	0.00259	CcSEcCtD
Pentoxifylline—Headache—Capecitabine—esophageal cancer	0.000579	0.00258	CcSEcCtD
Pentoxifylline—Feeling abnormal—Methotrexate—esophageal cancer	0.000567	0.00253	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000563	0.00251	CcSEcCtD
Pentoxifylline—Nausea—Capecitabine—esophageal cancer	0.000549	0.00245	CcSEcCtD
Pentoxifylline—Urticaria—Methotrexate—esophageal cancer	0.000547	0.00243	CcSEcCtD
Pentoxifylline—Body temperature increased—Methotrexate—esophageal cancer	0.000544	0.00242	CcSEcCtD
Pentoxifylline—Abdominal pain—Methotrexate—esophageal cancer	0.000544	0.00242	CcSEcCtD
Pentoxifylline—Hypersensitivity—Methotrexate—esophageal cancer	0.000507	0.00226	CcSEcCtD
Pentoxifylline—Asthenia—Methotrexate—esophageal cancer	0.000494	0.0022	CcSEcCtD
Pentoxifylline—Pruritus—Methotrexate—esophageal cancer	0.000487	0.00217	CcSEcCtD
Pentoxifylline—Diarrhoea—Methotrexate—esophageal cancer	0.000471	0.0021	CcSEcCtD
Pentoxifylline—Dizziness—Methotrexate—esophageal cancer	0.000455	0.00203	CcSEcCtD
Pentoxifylline—Vomiting—Methotrexate—esophageal cancer	0.000438	0.00195	CcSEcCtD
Pentoxifylline—Rash—Methotrexate—esophageal cancer	0.000434	0.00193	CcSEcCtD
Pentoxifylline—Dermatitis—Methotrexate—esophageal cancer	0.000433	0.00193	CcSEcCtD
Pentoxifylline—Headache—Methotrexate—esophageal cancer	0.000431	0.00192	CcSEcCtD
Pentoxifylline—Nausea—Methotrexate—esophageal cancer	0.000409	0.00182	CcSEcCtD
Pentoxifylline—ADORA2A—GPCR downstream signaling—CXCL2—esophageal cancer	0.000293	0.000545	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—WWOX—esophageal cancer	0.000291	0.000541	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—ELMO1—esophageal cancer	0.00029	0.000539	CbGpPWpGaD
Pentoxifylline—CYP1A2—Biological oxidations—PTGS1—esophageal cancer	0.000289	0.000538	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000288	0.000536	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—PDE4D—esophageal cancer	0.000286	0.000531	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—AKAP13—esophageal cancer	0.000284	0.000527	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—esophageal cancer	0.000278	0.000517	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—FKBP1A—esophageal cancer	0.000277	0.000515	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—ANXA1—esophageal cancer	0.000273	0.000506	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—ERBB2—esophageal cancer	0.000272	0.000505	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—GNG7—esophageal cancer	0.000272	0.000505	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—ELMO1—esophageal cancer	0.000272	0.000505	CbGpPWpGaD
Pentoxifylline—ADORA1—Circadian rythm related genes—TP53—esophageal cancer	0.000272	0.000505	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—WIF1—esophageal cancer	0.000271	0.000503	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—ELMO1—esophageal cancer	0.000269	0.000499	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—CXCL2—esophageal cancer	0.000266	0.000495	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—AKAP13—esophageal cancer	0.000266	0.000494	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—SST—esophageal cancer	0.000265	0.000493	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor—EP300—esophageal cancer	0.000265	0.000492	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—esophageal cancer	0.000265	0.000492	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—AKAP13—esophageal cancer	0.000263	0.000488	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000262	0.000487	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—PDE4D—esophageal cancer	0.00026	0.000482	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—GHRL—esophageal cancer	0.000258	0.00048	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—XIAP—esophageal cancer	0.000255	0.000473	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—CREBBP—esophageal cancer	0.000251	0.000467	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CSNK1A1—esophageal cancer	0.00025	0.000464	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—ANXA1—esophageal cancer	0.000247	0.00046	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—GNG7—esophageal cancer	0.000247	0.000459	CbGpPWpGaD
Pentoxifylline—CYP1A2—Biological oxidations—CYP1B1—esophageal cancer	0.000246	0.000457	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000245	0.000456	CbGpPWpGaD
Pentoxifylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—EGFR—esophageal cancer	0.000245	0.000455	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—PDE4D—esophageal cancer	0.000243	0.000452	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000243	0.000451	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000242	0.00045	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CTNNA1—esophageal cancer	0.000241	0.000448	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—SST—esophageal cancer	0.000241	0.000447	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—PDE4D—esophageal cancer	0.00024	0.000446	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CXCL2—esophageal cancer	0.00024	0.000445	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	0.000237	0.000441	CbGpPWpGaD
Pentoxifylline—PDE5A—Hemostasis—PIK3CA—esophageal cancer	0.000237	0.00044	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—GHRL—esophageal cancer	0.000235	0.000436	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—PFN1—esophageal cancer	0.000234	0.000434	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—CDKN1A—esophageal cancer	0.000232	0.000432	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—XIAP—esophageal cancer	0.000231	0.00043	CbGpPWpGaD
Pentoxifylline—CYP1A2—Biological oxidations—CYP19A1—esophageal cancer	0.000231	0.00043	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—GNG7—esophageal cancer	0.000231	0.00043	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor—MYC—esophageal cancer	0.000231	0.000429	CbGpPWpGaD
Pentoxifylline—PDE5A—Hemostasis—TP53—esophageal cancer	0.000229	0.000425	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—GNG7—esophageal cancer	0.000228	0.000424	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000228	0.000424	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—esophageal cancer	0.000226	0.000419	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—esophageal cancer	0.000226	0.000419	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—NOS3—esophageal cancer	0.000225	0.000418	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—PSME2—esophageal cancer	0.000224	0.000416	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—PSME1—esophageal cancer	0.000224	0.000416	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—ANXA1—esophageal cancer	0.000223	0.000414	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CTNNA1—esophageal cancer	0.000219	0.000406	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CXCL2—esophageal cancer	0.000217	0.000404	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—XIAP—esophageal cancer	0.000217	0.000403	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—SST—esophageal cancer	0.000217	0.000403	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—XIAP—esophageal cancer	0.000214	0.000398	CbGpPWpGaD
Pentoxifylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—PIK3CA—esophageal cancer	0.000213	0.000395	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—GHRL—esophageal cancer	0.000211	0.000392	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—NOTCH3—esophageal cancer	0.000211	0.000392	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—ELMO1—esophageal cancer	0.00021	0.00039	CbGpPWpGaD
Pentoxifylline—ADORA2A—Circadian rythm related genes—TP53—esophageal cancer	0.00021	0.00039	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—FBXW7—esophageal cancer	0.000208	0.000386	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—PTGS2—esophageal cancer	0.000206	0.000382	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—AKAP13—esophageal cancer	0.000205	0.000381	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CTNNA1—esophageal cancer	0.000205	0.000381	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CXCL2—esophageal cancer	0.000204	0.000378	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—PSME1—esophageal cancer	0.000203	0.000378	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—PSME2—esophageal cancer	0.000203	0.000378	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CTNNA1—esophageal cancer	0.000202	0.000376	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—ANXA1—esophageal cancer	0.000202	0.000376	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CXCL2—esophageal cancer	0.000201	0.000374	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—SST—esophageal cancer	0.000197	0.000365	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—NOTCH3—esophageal cancer	0.000192	0.000356	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—GHRL—esophageal cancer	0.000192	0.000356	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—PSME2—esophageal cancer	0.00019	0.000354	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—PSME1—esophageal cancer	0.00019	0.000354	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000189	0.000352	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—NOTCH2—esophageal cancer	0.000189	0.000352	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—ANXA1—esophageal cancer	0.000189	0.000352	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—FBXW7—esophageal cancer	0.000189	0.00035	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—EGFR—esophageal cancer	0.000189	0.00035	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—PSME2—esophageal cancer	0.000188	0.000349	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—PSME1—esophageal cancer	0.000188	0.000349	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—PDE4D—esophageal cancer	0.000188	0.000349	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—ANXA1—esophageal cancer	0.000187	0.000348	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—SST—esophageal cancer	0.000184	0.000342	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—SST—esophageal cancer	0.000182	0.000338	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—NOTCH3—esophageal cancer	0.000179	0.000334	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—GHRL—esophageal cancer	0.000179	0.000334	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—GNG7—esophageal cancer	0.000178	0.000332	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—NOTCH3—esophageal cancer	0.000177	0.00033	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—GHRL—esophageal cancer	0.000177	0.00033	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—FBXW7—esophageal cancer	0.000177	0.000328	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—FBXW7—esophageal cancer	0.000174	0.000324	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—NOTCH2—esophageal cancer	0.000172	0.000319	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—EP300—esophageal cancer	0.000171	0.000318	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—TGFBR2—esophageal cancer	0.000168	0.000312	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—XIAP—esophageal cancer	0.000167	0.000311	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—PIK3CA—esophageal cancer	0.000164	0.000304	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—NOTCH2—esophageal cancer	0.000161	0.000299	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	0.00016	0.000298	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—NOTCH2—esophageal cancer	0.000159	0.000296	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—SMAD4—esophageal cancer	0.000159	0.000295	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CTNNA1—esophageal cancer	0.000158	0.000294	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CXCL2—esophageal cancer	0.000157	0.000292	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—TGFBR2—esophageal cancer	0.000153	0.000283	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—PSME2—esophageal cancer	0.000147	0.000273	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—PSME1—esophageal cancer	0.000147	0.000273	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—ANXA1—esophageal cancer	0.000146	0.000272	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—SMAD4—esophageal cancer	0.000144	0.000268	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—TGFBR2—esophageal cancer	0.000143	0.000265	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—SST—esophageal cancer	0.000142	0.000264	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—TGFBR2—esophageal cancer	0.000141	0.000262	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	0.00014	0.00026	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—GHRL—esophageal cancer	0.000139	0.000258	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—NOTCH3—esophageal cancer	0.000139	0.000258	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—FBXW7—esophageal cancer	0.000136	0.000253	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—SMAD4—esophageal cancer	0.000135	0.000251	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—SMAD4—esophageal cancer	0.000134	0.000248	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—HIF1A—esophageal cancer	0.00013	0.000242	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—PIK3CA—esophageal cancer	0.000127	0.000235	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—KDR—esophageal cancer	0.000124	0.000231	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—NOTCH2—esophageal cancer	0.000124	0.000231	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—BLVRB—esophageal cancer	0.000124	0.000231	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—SLC52A3—esophageal cancer	0.000124	0.000231	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—HIF1A—esophageal cancer	0.000118	0.000219	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—NOTCH1—esophageal cancer	0.000117	0.000218	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—KDR—esophageal cancer	0.000113	0.00021	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	0.000111	0.000206	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—HIF1A—esophageal cancer	0.000111	0.000206	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—TGFBR2—esophageal cancer	0.00011	0.000205	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—HIF1A—esophageal cancer	0.000109	0.000203	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—NOTCH1—esophageal cancer	0.000106	0.000198	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CREBBP—esophageal cancer	0.000106	0.000197	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—KDR—esophageal cancer	0.000106	0.000197	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—CA1—esophageal cancer	0.000106	0.000196	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—SLC10A2—esophageal cancer	0.000106	0.000196	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—KDR—esophageal cancer	0.000105	0.000194	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—EGFR—esophageal cancer	0.000104	0.000194	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—SMAD4—esophageal cancer	0.000104	0.000194	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—PIK3CA—esophageal cancer	9.98e-05	0.000185	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—NOTCH1—esophageal cancer	9.97e-05	0.000185	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—NOTCH1—esophageal cancer	9.85e-05	0.000183	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—CA2—esophageal cancer	9.67e-05	0.00018	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CREBBP—esophageal cancer	9.65e-05	0.000179	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—NOS3—esophageal cancer	9.51e-05	0.000177	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—EGFR—esophageal cancer	9.48e-05	0.000176	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	9.45e-05	0.000176	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—PIK3CA—esophageal cancer	9.06e-05	0.000168	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—PIK3CA—esophageal cancer	9.06e-05	0.000168	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CREBBP—esophageal cancer	9.04e-05	0.000168	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PLCE1—esophageal cancer	8.99e-05	0.000167	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—ADH7—esophageal cancer	8.99e-05	0.000167	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CREBBP—esophageal cancer	8.93e-05	0.000166	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—ERBB2—esophageal cancer	8.9e-05	0.000165	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	8.88e-05	0.000165	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—EGFR—esophageal cancer	8.88e-05	0.000165	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—EGFR—esophageal cancer	8.77e-05	0.000163	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—NOS3—esophageal cancer	8.64e-05	0.000161	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—HIF1A—esophageal cancer	8.54e-05	0.000159	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—PIK3CA—esophageal cancer	8.49e-05	0.000158	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—PIK3CA—esophageal cancer	8.38e-05	0.000156	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—PIK3CA—esophageal cancer	8.23e-05	0.000153	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—KDR—esophageal cancer	8.17e-05	0.000152	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—NOS3—esophageal cancer	8.09e-05	0.00015	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—ERBB2—esophageal cancer	8.08e-05	0.00015	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—NOS3—esophageal cancer	7.99e-05	0.000149	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—ADH1B—esophageal cancer	7.88e-05	0.000146	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CCND1—esophageal cancer	7.86e-05	0.000146	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—PIK3CA—esophageal cancer	7.71e-05	0.000143	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—NOTCH1—esophageal cancer	7.69e-05	0.000143	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—PIK3CA—esophageal cancer	7.61e-05	0.000141	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CDKN1A—esophageal cancer	7.61e-05	0.000141	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—ERBB2—esophageal cancer	7.57e-05	0.000141	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—TYMP—esophageal cancer	7.53e-05	0.00014	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—ERBB2—esophageal cancer	7.48e-05	0.000139	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—CYP26A1—esophageal cancer	7.32e-05	0.000136	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—EP300—esophageal cancer	7.24e-05	0.000134	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CCND1—esophageal cancer	7.14e-05	0.000133	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—ALOX15—esophageal cancer	7.14e-05	0.000133	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CREBBP—esophageal cancer	6.98e-05	0.00013	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CDKN1A—esophageal cancer	6.91e-05	0.000128	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—EGFR—esophageal cancer	6.85e-05	0.000127	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—TPI1—esophageal cancer	6.81e-05	0.000127	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—GSTO1—esophageal cancer	6.81e-05	0.000127	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CCND1—esophageal cancer	6.69e-05	0.000124	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CCND1—esophageal cancer	6.61e-05	0.000123	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—EP300—esophageal cancer	6.57e-05	0.000122	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—PIK3CA—esophageal cancer	6.55e-05	0.000122	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—ALDOB—esophageal cancer	6.53e-05	0.000121	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CDKN1A—esophageal cancer	6.47e-05	0.00012	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CDKN1A—esophageal cancer	6.39e-05	0.000119	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—MYC—esophageal cancer	6.31e-05	0.000117	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—GAPDH—esophageal cancer	6.28e-05	0.000117	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—NOS3—esophageal cancer	6.25e-05	0.000116	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—CRABP1—esophageal cancer	6.23e-05	0.000116	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—EGFR—esophageal cancer	6.17e-05	0.000115	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—EP300—esophageal cancer	6.15e-05	0.000114	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—EP300—esophageal cancer	6.08e-05	0.000113	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—PIK3CA—esophageal cancer	5.95e-05	0.000111	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—GNG7—esophageal cancer	5.92e-05	0.00011	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—ERBB2—esophageal cancer	5.84e-05	0.000109	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—MYC—esophageal cancer	5.73e-05	0.000106	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—EGFR—esophageal cancer	5.6e-05	0.000104	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—ALDH2—esophageal cancer	5.55e-05	0.000103	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—MYC—esophageal cancer	5.36e-05	9.96e-05	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—PIK3CA—esophageal cancer	5.35e-05	9.95e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—MYC—esophageal cancer	5.3e-05	9.85e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—GSTT1—esophageal cancer	5.28e-05	9.81e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—EGFR—esophageal cancer	5.24e-05	9.75e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—CYP2A6—esophageal cancer	5.22e-05	9.7e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	5.2e-05	9.66e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—EGFR—esophageal cancer	5.18e-05	9.63e-05	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—TP53—esophageal cancer	5.18e-05	9.62e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CCND1—esophageal cancer	5.16e-05	9.59e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CDKN1A—esophageal cancer	4.99e-05	9.28e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—ENO1—esophageal cancer	4.95e-05	9.19e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PTGS1—esophageal cancer	4.95e-05	9.19e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PSME2—esophageal cancer	4.88e-05	9.06e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PSME1—esophageal cancer	4.88e-05	9.06e-05	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—PIK3CA—esophageal cancer	4.86e-05	9.03e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—EP300—esophageal cancer	4.75e-05	8.83e-05	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—TP53—esophageal cancer	4.7e-05	8.74e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—PIK3CA—esophageal cancer	4.55e-05	8.46e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—PIK3CA—esophageal cancer	4.5e-05	8.36e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—TP53—esophageal cancer	4.4e-05	8.18e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—TP53—esophageal cancer	4.35e-05	8.09e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	4.26e-05	7.91e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—CYP1B1—esophageal cancer	4.21e-05	7.82e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—MYC—esophageal cancer	4.14e-05	7.69e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—EGFR—esophageal cancer	4.05e-05	7.52e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—CYP19A1—esophageal cancer	3.96e-05	7.35e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—HMOX1—esophageal cancer	3.61e-05	6.71e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	3.54e-05	6.58e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—PIK3CA—esophageal cancer	3.51e-05	6.53e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—ABCB1—esophageal cancer	3.46e-05	6.44e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—TP53—esophageal cancer	3.4e-05	6.32e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	2.62e-05	4.87e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—CREBBP—esophageal cancer	2.32e-05	4.3e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—NOS3—esophageal cancer	2.07e-05	3.85e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PTGS2—esophageal cancer	1.9e-05	3.52e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—EP300—esophageal cancer	1.58e-05	2.93e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PIK3CA—esophageal cancer	1.17e-05	2.17e-05	CbGpPWpGaD
